The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(Benzo[d][1,3]dioxol-5-yl)-1,2-dihydro-4-oxoquinazolin-3(4H)-yl)-N'-((benzo[d][1,3]dioxol-5-yl)methylene)acetohydrazide ID: ALA4071879
PubChem CID: 137639121
Max Phase: Preclinical
Molecular Formula: C25H20N4O6
Molecular Weight: 472.46
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CN1C(=O)c2ccccc2NC1c1ccc2c(c1)OCO2)N/N=C/c1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C25H20N4O6/c30-23(28-26-11-15-5-7-19-21(9-15)34-13-32-19)12-29-24(16-6-8-20-22(10-16)35-14-33-20)27-18-4-2-1-3-17(18)25(29)31/h1-11,24,27H,12-14H2,(H,28,30)/b26-11+
Standard InChI Key: VOWGULMGFQLWBG-KBKYJPHKSA-N
Molfile:
RDKit 2D
35 40 0 0 0 0 0 0 0 0999 V2000
8.2572 -3.4049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2560 -4.2245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9641 -4.6334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9623 -2.9961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6709 -3.4013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6697 -4.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3759 -4.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0878 -4.2240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0890 -3.4033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3783 -2.9897 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3737 -5.4482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7977 -2.9964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7944 -4.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7921 -5.4517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4987 -5.8623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0833 -5.8583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4964 -6.6795 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2029 -7.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2007 -7.9072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4918 -8.3087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4891 -9.1251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9066 -8.3104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9074 -9.1255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1991 -9.5381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3726 -10.3393 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1882 -10.4219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5187 -9.6717 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5028 -3.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2110 -3.0052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7965 -2.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5018 -1.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2111 -2.1862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8196 -1.6380 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4862 -0.8899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6718 -0.9759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
7 11 2 0
9 12 1 0
8 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 24 2 0
23 22 2 0
22 19 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
12 28 2 0
28 29 1 0
29 32 2 0
31 30 2 0
30 12 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 31 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 472.46Molecular Weight (Monoisotopic): 472.1383AlogP: 2.86#Rotatable Bonds: 5Polar Surface Area: 110.72Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.62CX Basic pKa: 1.24CX LogP: 3.33CX LogD: 3.33Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.43Np Likeness Score: -0.96
References 1. Khattab SN, Haiba NS, Asal AM, Bekhit AA, Guemei AA, Amer A, El-Faham A.. (2017) Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives., 27 (4): [PMID:28087274 ] [10.1016/j.bmcl.2017.01.003 ]